BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Holbrook JA, Jarosz-Griffiths HH, Caseley E, Lara-Reyna S, Poulter JA, Williams-Gray CH, Peckham D, McDermott MF. Neurodegenerative Disease and the NLRP3 Inflammasome. Front Pharmacol 2021;12:643254. [PMID: 33776778 DOI: 10.3389/fphar.2021.643254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Khot M, Sood A, Tryphena KP, Khan S, Srivastava S, Singh SB, Khatri DK. NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's disease. Eur J Pharmacol 2022;:175300. [PMID: 36167151 DOI: 10.1016/j.ejphar.2022.175300] [Reference Citation Analysis]
2 de Oliveira Furlam T, Roque IG, Machado da Silva EW, Vianna PP, Costa Valadão PA, Guatimosim C, Teixeira AL, de Miranda AS. Inflammasome activation and assembly in Huntington's disease. Mol Immunol 2022;151:134-42. [PMID: 36126501 DOI: 10.1016/j.molimm.2022.09.002] [Reference Citation Analysis]
3 Sun G, Zhang R, Liu C, Meng W, Pang Q. Itaconate Attenuates Neuroinflammation and Exerts Dopamine Neuroprotection in Parkinson's Disease through Inhibiting NLRP3 Inflammasome. Brain Sci 2022;12:1255. [PMID: 36138991 DOI: 10.3390/brainsci12091255] [Reference Citation Analysis]
4 Zhang J, Wirtz S. Does Pyroptosis Play a Role in Inflammasome-Related Disorders? Int J Mol Sci 2022;23:10453. [PMID: 36142364 DOI: 10.3390/ijms231810453] [Reference Citation Analysis]
5 Castillo G, Barrios-Arpi L, Ramos-Gonzalez M, Vidal P, Gonzales-Irribarren A, Ramos-Cevallos N, Rodríguez JL. Neurotoxicity associated with oxidative stress and inflammasome gene expression induced by allethrin in SH-SY5Y cells. Toxicol Ind Health 2022;:7482337221089585. [PMID: 36074087 DOI: 10.1177/07482337221089585] [Reference Citation Analysis]
6 Jiang H, Zhang Y, Yue J, Shi Y, Xiao B, Xiao W, Luo Z. Non-coding RNAs: The Neuroinflammatory Regulators in Neurodegenerative Diseases. Front Neurol 2022;13:929290. [DOI: 10.3389/fneur.2022.929290] [Reference Citation Analysis]
7 Suresh P, Jasmin S, Yen Y, Hsu H, Varinthra P, Pairojana T, Chen C, Liu IY. Attenuation of HECT-E3 ligase expression rescued memory deficits in 3xTg-AD mice. Front Aging Neurosci 2022;14:916904. [DOI: 10.3389/fnagi.2022.916904] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cheng TM, Chu HY, Huang HM, Li ZL, Chen CY, Shih YJ, Whang-Peng J, Cheng RH, Mo JK, Lin HY, Wang K. Toxicologic Concerns with Current Medical Nanoparticles. Int J Mol Sci 2022;23:7597. [PMID: 35886945 DOI: 10.3390/ijms23147597] [Reference Citation Analysis]
9 Huang C, Ogawa R. Role of Inflammasomes in Keloids and Hypertrophic Scars-Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis. Int J Mol Sci 2022;23:6820. [PMID: 35743263 DOI: 10.3390/ijms23126820] [Reference Citation Analysis]
10 Lee S, Ryu SM, Kim DH, Lee YE, Lee SJ, Kang S, Kim JS, Lee SI. Neuroprotective effect of Geijigadaehwang-tang against trimethyltin-induced hippocampal neurodegeneration: An in vitro and in vivo study. J Ethnopharmacol 2022;296:115451. [PMID: 35724744 DOI: 10.1016/j.jep.2022.115451] [Reference Citation Analysis]
11 Li T, Lu L, Pember E, Li X, Zhang B, Zhu Z. New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer's Disease and Its Potential for Therapeutic Intervention. Cells 2022;11:1925. [PMID: 35741054 DOI: 10.3390/cells11121925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Qin Q, Gu Z, Li F, Pan Y, Zhang T, Fang Y, Zhang L. A Diagnostic Model for Alzheimer’s Disease Based on Blood Levels of Autophagy-Related Genes. Front Aging Neurosci 2022;14:881890. [DOI: 10.3389/fnagi.2022.881890] [Reference Citation Analysis]
13 Merighi S, Nigro M, Travagli A, Pasquini S, Borea PA, Varani K, Vincenzi F, Gessi S. A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? Int J Mol Sci 2022;23:5056. [PMID: 35563447 DOI: 10.3390/ijms23095056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Mamais A, Kaganovich A, Harvey K. Convergence of signalling pathways in innate immune responses and genetic formof Parkinson’s disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105721] [Reference Citation Analysis]
15 Ding J, Shen L, Ye Y, Hu S, Ren Z, Liu T, Dai J, Li Z, Wang J, Luo Y, Zhang Q, Zhang X, Qi X, Huang J. Inflammasome Inhibition Prevents Motor Deficit and Cerebellar Degeneration Induced by Chronic Methamphetamine Administration. Front Mol Neurosci 2022;15:861340. [DOI: 10.3389/fnmol.2022.861340] [Reference Citation Analysis]
16 Wareham LK, Liddelow SA, Temple S, Benowitz LI, Di Polo A, Wellington C, Goldberg JL, He Z, Duan X, Bu G, Davis AA, Shekhar K, Torre AL, Chan DC, Canto-soler MV, Flanagan JG, Subramanian P, Rossi S, Brunner T, Bovenkamp DE, Calkins DJ. Solving neurodegeneration: common mechanisms and strategies for new treatments. Mol Neurodegeneration 2022;17. [DOI: 10.1186/s13024-022-00524-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
17 Ma Z, Tang P, Dong W, Lu Y, Tan B, Zhou N, Hao J, Shen J, Hu Z. SIRT1 alleviates IL-1β induced nucleus pulposus cells pyroptosis via mitophagy in intervertebral disc degeneration. Int Immunopharmacol 2022;107:108671. [PMID: 35305383 DOI: 10.1016/j.intimp.2022.108671] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 O'Day DH, Huber RJ. Calmodulin binding proteins and neuroinflammation in multiple neurodegenerative diseases. BMC Neurosci 2022;23:10. [PMID: 35246032 DOI: 10.1186/s12868-022-00695-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Jia Y, Zhang Q, Liu Z, Pan P, Jia Y, Zhu P, Jiao Y, Kang G, Ma X. The role of α5-nicotinic acetylcholine receptor/NLRP3 signaling pathway in lung adenocarcinoma cell proliferation and migration. Toxicology 2022. [DOI: 10.1016/j.tox.2022.153120] [Reference Citation Analysis]
20 Satoh T, Trudler D, Oh C, Lipton SA. Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome. Antioxidants 2022;11:124. [DOI: 10.3390/antiox11010124] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
21 Zarneshan SN, Fakhri S, Khan H. Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106099] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
22 Cui J, Zhao S, Li Y, Zhang D, Wang B, Xie J, Wang J. Regulated cell death: discovery, features and implications for neurodegenerative diseases. Cell Commun Signal 2021;19:120. [PMID: 34922574 DOI: 10.1186/s12964-021-00799-8] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Safar MM, Abdelkader NF, Ramadan E, Kortam MA, Mohamed AF. Novel mechanistic insights towards the repositioning of alogliptin in Parkinson's disease. Life Sci 2021;287:120132. [PMID: 34774622 DOI: 10.1016/j.lfs.2021.120132] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Hensley K, Danekas A, Farrell W, Garcia T, Mehboob W, White M. At the intersection of sulfur redox chemistry, cellular signal transduction and proteostasis: A useful perspective from which to understand and treat neurodegeneration. Free Radic Biol Med 2022;178:161-73. [PMID: 34863876 DOI: 10.1016/j.freeradbiomed.2021.11.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
25 Litwiniuk A, Baranowska-Bik A, Domańska A, Kalisz M, Bik W. Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases. Pharmaceuticals (Basel) 2021;14:1221. [PMID: 34959622 DOI: 10.3390/ph14121221] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Leite AOF, Bento Torres Neto J, Dos Reis RR, Sobral LL, de Souza ACP, Trévia N, de Oliveira RB, Lins NAA, Diniz DG, Diniz JAP, Vasconcelos PFDC, Anthony DC, Brites D, Picanço Diniz CW. Unwanted Exacerbation of the Immune Response in Neurodegenerative Disease: A Time to Review the Impact. Front Cell Neurosci 2021;15:749595. [PMID: 34744633 DOI: 10.3389/fncel.2021.749595] [Reference Citation Analysis]
27 Marcuzzi A, Melloni E, Zauli G, Romani A, Secchiero P, Maximova N, Rimondi E. Autoinflammatory Diseases and Cytokine Storms-Imbalances of Innate and Adaptative Immunity. Int J Mol Sci 2021;22:11241. [PMID: 34681901 DOI: 10.3390/ijms222011241] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Cichon N, Dziedzic A, Gorniak L, Miller E, Bijak M, Starosta M, Saluk-Bijak J. Unusual Bioactive Compounds with Antioxidant Properties in Adjuvant Therapy Supporting Cognition Impairment in Age-Related Neurodegenerative Disorders. Int J Mol Sci 2021;22:10707. [PMID: 34639048 DOI: 10.3390/ijms221910707] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
29 Wang J, Zhang XN, Fang JN, Hua FF, Han JY, Yuan ZQ, Xie AM. The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson's disease. Neural Regen Res 2022;17:898-904. [PMID: 34472491 DOI: 10.4103/1673-5374.323077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
30 Mishra A, Bandopadhyay R, Singh PK, Mishra PS, Sharma N, Khurana N. Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside. Metab Brain Dis 2021. [PMID: 34387831 DOI: 10.1007/s11011-021-00806-4] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
31 Gastaldi S, Boscaro V, Gianquinto E, Sandall CF, Giorgis M, Marini E, Blua F, Gallicchio M, Spyrakis F, MacDonald JA, Bertinaria M. Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor. Molecules 2021;26:3975. [PMID: 34209843 DOI: 10.3390/molecules26133975] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
32 Ali M, Gupta M, Wani A, Sharma A, Abdullaha M, Kour D, Choudhary S, Bharate SB, Singh G, Kumar A. IIIM-941, a Stilbene Derivative Inhibits NLRP3 Inflammasome Activation by Inducing Autophagy. Front Pharmacol 2021;12:695712. [PMID: 34248643 DOI: 10.3389/fphar.2021.695712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Gupta M, Wani A, Ahsan AU, Ali M, Chibber P, Singh S, Digra SK, Datt M, Bharate SB, Vishwakarma RA, Singh G, Kumar A. Safranal inhibits NLRP3 inflammasome activation by preventing ASC oligomerization. Toxicol Appl Pharmacol 2021;423:115582. [PMID: 34019860 DOI: 10.1016/j.taap.2021.115582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]